PT - JOURNAL ARTICLE AU - Clementina López-Medina AU - Anna Molto AU - Joachim Sieper AU - Tuncay Duruöz AU - Uta Kiltz AU - Bassel Elzorkany AU - Najia Hajjaj-Hassouni AU - Ruben Burgos-Vargas AU - José Maldonado-Cocco AU - Nelly Ziade AU - Meghna Gavali AU - Victoria Navarro-Compan AU - Shue-Fen Luo AU - Sara Monti AU - Kim Tae-Jong AU - Mitsumasa Kishimoto AU - F M Pimentel-Santos AU - Jieruo Gu AU - Ruxandra Schiotis AU - Floris A van Gaalen AU - Pál Geher AU - Marina Magrey AU - Sebastián E Ibáñez Vodnizza AU - Wilson Bautista-Molano AU - Walter Maksymowych AU - Pedro M Machado AU - Robert Landewé AU - Desirée van der Heijde AU - Maxime Dougados TI - Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study AID - 10.1136/rmdopen-2020-001450 DP - 2021 Jan 01 TA - RMD Open PG - e001450 VI - 7 IP - 1 4099 - http://rmdopen.bmj.com/content/7/1/e001450.short 4100 - http://rmdopen.bmj.com/content/7/1/e001450.full SO - RMD Open2021 Jan 01; 7 AB - Objectives To characterise peripheral musculoskeletal involvement in patients with spondyloarthritis (SpA) including psoriatic arthritis (PsA), across the world.Methods Cross-sectional study with 24 participating countries. Patients with a diagnosis of axial SpA (axSpA), peripheral SpA (pSpA) or PsA according to their rheumatologist were included. The investigators were asked which diagnosis out of a list of six (axSpA, PsA, pSpA, inflammatory bowel disease-associated SpA, reactive arthritis or juvenile SpA (Juv-SpA)) fitted the patient best. Peripheral manifestations (ie, peripheral joint disease, enthesitis, dactylitis and root joint disease), their localisation and treatments were evaluated.Results A total of 4465 patients were included (61% men, mean age 44.5 years) from four geographic areas: Latin America (n=538), Europe plus North America (n=1677), Asia (n=975) and the Middle East plus North Africa (n=1275). Of those, 78% had ever suffered from at least one peripheral musculoskeletal manifestation; 57% had peripheral joint disease, 44% had enthesitis and 15% had dactylitis. Latin American had far more often peripheral joint disease (80%) than patients from other areas. Patients with PsA had predominantly upper limb and small joint involvement (52%).Hip and shoulder involvement was found in 34% of patients. The prevalence of enthesitis ranged between 41% in patients with axSpA and 65% in patients with Juv-SpA. Dactylitis was most frequent among patients with PsA (37%).Conclusion These results suggest that all peripheral features can be found in all subtypes of SpA, and that differences are quantitative rather than qualitative. In a high proportion of patients, axial and peripheral manifestations coincided. These findings reconfirm SpA clinical subtypes are descendants of the same underlying disease, called SpA.